IYH: Healthcare Dashboard For January
Portfolio Pulse from
The healthcare sector is overvalued by 12% compared to 11-year averages, with pharmaceuticals/biotechnology showing low value and quality scores. The iShares U.S. Healthcare ETF (IYH) has underperformed compared to XLV, which has lower fees and higher trading volume, making XLV a preferable choice for investors.
January 20, 2025 | 11:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The iShares U.S. Healthcare ETF (IYH) is underperforming compared to XLV due to higher fees and lower trading volume, making it a less attractive option for investors.
IYH is underperforming compared to XLV, which has lower fees and higher trading volume. This makes IYH less attractive to investors, likely leading to a short-term negative impact on its price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The Health Care Select Sector SPDR Fund (XLV) is outperforming IYH due to lower fees and higher trading volume, making it a more attractive option for investors.
XLV is outperforming IYH due to its lower fees and higher trading volume, making it a more attractive option for investors seeking exposure to the healthcare sector. This is likely to have a positive short-term impact on XLV's price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 70